These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 6811441)

  • 21. Tumor necrosis factor, alone or in combination with IL-2, but not IFN-gamma, is associated with macrophage killing of Mycobacterium avium complex.
    Bermudez LE; Young LS
    J Immunol; 1988 May; 140(9):3006-13. PubMed ID: 2834450
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mouse macrophages stimulated by recombinant gamma interferon to kill tumor cells are not bactericidal for the facultative intracellular bacterium Listeria monocytogenes.
    Campbell PA; Canono BP; Cook JL
    Infect Immun; 1988 May; 56(5):1371-5. PubMed ID: 3128484
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhanced superoxide release and tumoricidal activity by a postlavage, in situ pulmonary macrophage population in response to activation by Mycobacterium bovis BCG exposure.
    Drath DB
    Infect Immun; 1985 Jul; 49(1):72-5. PubMed ID: 2989181
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NMAAP1 Expressed in BCG-Activated Macrophage Promotes M1 Macrophage Polarization.
    Liu Q; Tian Y; Zhao X; Jing H; Xie Q; Li P; Li D; Yan D; Zhu X
    Mol Cells; 2015 Oct; 38(10):886-94. PubMed ID: 26429502
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mycoplasma arginini enhances cytotoxicity of thioglycollate-elicited murine macrophages toward YAC-1 tumor cells through production of NO.
    Ribeiro-Dias F; Russo M; Marzagão Barbuto JA; Fernandes do Nascimento FR; Timenetsky J; Jancar S
    J Leukoc Biol; 1999 Jun; 65(6):808-14. PubMed ID: 10380903
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hydrocortisone treatment of BCG-infected mice impairs the activation and enhancement of antimicrobial activity of peritoneal macrophages.
    Stokvis H; Langermans JA; de Backer-Vledder E; van der Hulst ME; van Furth R
    Scand J Immunol; 1992 Aug; 36(2):299-305. PubMed ID: 1502497
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thioglycollate-elicited murine macrophages are cytotoxic to Mycoplasma arginini-infected YAC-1 tumor cells.
    Ribeiro-Dias F; Russo M; Nascimento FR; Barbuto JA; Timenetsky J; Jancar S
    Braz J Med Biol Res; 1998 Nov; 31(11):1425-8. PubMed ID: 9921279
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of Mycobacterium bovis BCG infection on regulation of L-arginine uptake and synthesis of reactive nitrogen intermediates in J774.1 murine macrophages.
    Peteroy-Kelly M; Venketaraman V; Connell ND
    Infect Immun; 2001 Sep; 69(9):5823-31. PubMed ID: 11500460
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Colony-stimulating factors and regulation of macrophage tumoricidal and microbicidal activities.
    Ralph P; Nacy CA; Meltzer MS; Williams N; Nakoinz I; Leonard EJ
    Cell Immunol; 1983 Feb; 76(1):10-21. PubMed ID: 6600975
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of cytokine profiles by the Mycoplasma superantigen Mycoplasma arthritidis mitogen parallels susceptibility to arthritis induced by M. arthritidis.
    Mu HH; Sawitzke AD; Cole BC
    Infect Immun; 2000 Mar; 68(3):1142-9. PubMed ID: 10678918
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Abilities of activated macrophages to manifest tumoricidal activity and to generate reactive nitrogen intermediates: a comparative study in vitro and ex vivo.
    Keller R; Keist R
    Biochem Biophys Res Commun; 1989 Nov; 164(3):968-73. PubMed ID: 2511844
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Macrophage activation for tumor cytotoxicity: genetic variation in macrophage tumoricidal capacity among mouse strains.
    Boraschi D; Meltzer MS
    Cell Immunol; 1979 Jun; 45(1):188-94. PubMed ID: 378423
    [No Abstract]   [Full Text] [Related]  

  • 33. Ontogeny of murine macrophages: functions related to antigen presentation.
    Lu CY; Unanue ER
    Infect Immun; 1982 Apr; 36(1):169-75. PubMed ID: 6804386
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages.
    Chan J; Xing Y; Magliozzo RS; Bloom BR
    J Exp Med; 1992 Apr; 175(4):1111-22. PubMed ID: 1552282
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Defective tumoricidal capacity of macrophages from A/J mice. I. Characterization of the macrophage cytotoxic defect after in vivo and in vitro activation stimuli.
    Boraschi D; Meltzer MS
    J Immunol; 1979 Apr; 122(4):1587-91. PubMed ID: 376720
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Macrophage activation to kill Leishmania tropica: characterization of a T cell-derived factor that suppresses lymphokine-induced intracellular destruction of amastigotes.
    Nacy CA
    J Immunol; 1984 Jul; 133(1):448-53. PubMed ID: 6202789
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Divergent changes in antimicrobial activity after immunologic activation of mouse peritoneal macrophages.
    van Dissel JT; Stikkelbroeck JJ; van den Barselaar MT; Sluiter W; Leijh PC; van Furth R
    J Immunol; 1987 Sep; 139(5):1665-72. PubMed ID: 2957432
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Study of the mechanisms of killing of Mycobacterium bovis BCG by apoptosis in J774 murine macrophages.
    Ahmad A; Khan M; Raykundalia C; Catty D
    J Pak Med Assoc; 1999 Nov; 49(11):273-8. PubMed ID: 10647239
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of macrophage activation on killing of Listeria monocytogenes. Roles of reactive oxygen or nitrogen intermediates, rate of phagocytosis, and retention of bacteria in endosomes.
    Higginbotham JN; Lin TL; Pruett SB
    Clin Exp Immunol; 1992 Jun; 88(3):492-8. PubMed ID: 1606735
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional studies on mouse macrophages activated by phospholipids from Listeria monocytogenes and Aspergillus fumigatus.
    Jakoniuk P; Borowski J; Talarczyk J
    Arch Immunol Ther Exp (Warsz); 1983; 31(4):523-30. PubMed ID: 6422902
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.